Form 4: Medifast CEO Daniel Chard Receives Stock Grant

Daniel Chard, Chairman & CEO of Medifast, Inc., reports the acquisition of restricted stock units.

Summary

• Daniel R Chard, the Chairman & CEO of Medifast Inc., filed a Form 4 on March 27, 2025.
• The report details changes in his beneficial ownership of Medifast stock.
• Chard acquired 124,953 shares of common stock through a grant of restricted stock units.
• These restricted stock units were granted under the 2012 Share Incentive Plan.
• The restricted stock units will vest in three equal annual installments starting on the first anniversary of the grant date.
• Each restricted stock unit represents a contingent right to receive one share of Medifast's common stock.
• Following the transaction, Chard directly owns 176,246 shares of Medifast common stock.
• Additionally, 149,317.352 shares are indirectly owned through The Dan and Allyson Family Irrevocable Trust, for which Chard is the Settlor and Investment Trustee.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a standard executive compensation practice, indicating confidence in the company's future performance.

Positives

• The grant of restricted stock units aligns the CEO's interests with those of the shareholders.
• The vesting schedule encourages long-term performance and commitment from the CEO.

Future Outlook

The restricted stock units will vest in three equal annual installments beginning on the first anniversary of the grant date, suggesting a continued commitment from the CEO.

Industry Context

Stock grants are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Executive compensation packages, including stock grants, are common across the industry.
• Companies like Herbalife Nutrition and Nu Skin Enterprises also utilize stock-based compensation to incentivize their executives.
• The size and vesting schedule of the grant would need to be compared to peer companies to assess its competitiveness.

Stakeholder Impact

• Shareholders may view the stock grant as a positive sign, aligning management's interests with the company's long-term success.
• Employees may see the grant as a sign of the company's commitment to its leadership.

Next Steps

• The restricted stock units will vest annually over the next three years.

Key Dates

Keywords

Medifast, Daniel Chard, restricted stock units, Form 4, beneficial ownership, stock grant, MEDI